Niels Bergsland
0000-0002-7792-0433
University at Buffalo
81 papers found
Refreshing results…
A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS
Five-Year Longitudinal Study of Neck Vessel Cross-Sectional Area in Multiple Sclerosis
Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study
Hemostasis biomarkers in multiple sclerosis
Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study
Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis: Atrophied Lesions in MS
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures
Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: An open-label two-arm trial
Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus
Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing–remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly
Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclerosis
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis
Missing publications? Search for publications with a matching author name.